11 Dec 2020

Claritas HealthTech receives Class A Medical Device Registration from Health Sciences Authority Singapore

Claritas HealthTech

Singapore, 11 December 2020 – Singapore-based Claritas HealthTech Pte. Ltd. (“Claritas”), is pleased to announce that its image enhancement software product for radiology, namely, iRad has been registered with the Health Sciences Authority of Singapore (HSA) as Class A Medical Device.

Claritas is a radiology software company that enables doctors and physicians to make accurate diagnoses and improve their patient lives with enhanced medical image processing and interpretation. In the fields of image enhancement, Machine Vision (MV), and Artificial Intelligence (AI), Claritas conducts research and development to develop powerful and effective technologies. Their products ensure cost and time efficiency for patients, on the account of re-testing, insurance and malpractice claims that often result from a misdiagnosis.

Imaging plays a pivotal role in the diagnostic process for many patients; however, the impact of diagnostic errors is considerable. With a worldwide annual estimate of 40 million diagnostic errors that involve imaging, medical errors have also resulted in wasteful healthcare spending, ranging from $17 billion to $29 billion annually. In the face of COVID-19, acceleration in healthcare digital transformation has indicated the urgent need for greater efficiency and responsiveness. From identifying cases to determining the diagnosis, more demand will be inevitably placed on radiology departments due to the rapidly changing circumstances in healthcare.

With Claritas HealthTech registered under the Health Sciences Authority Singapore (HSA) as a class A Medical Device Manufacturer, this enables the company to manufacture, import and wholesale medical devices in Singapore. Already established among renowned healthcare research organizations in Singapore and Indonesia, Claritas HealthTech aims to continue their expansion with physician groups and teleradiology practices across Asia, North America, and the United Kingdom. Beyond medical image processing and image enhancement products, Claritas will also be releasing several medical AI tools to help clinicians in rapid and accurate detection of abnormalities.

For more information on Claritas HealthTech, please visit:

For Media Enquiries, please contact:

Devika Dutt

Co-Founders COO

(65) 9795 1921

About Claritas HealthTech Pte. Ltd.

Claritas is incorporated and headquartered in Singapore. Claritas conducts research and development in the fields of image enhancement, machine vision and artificial intelligence (“AI”) with a focus on medical image processing and AI assisted interpretation. Claritas aims to transform the diagnostics industry with powerful and effective software products created using image enhancement and AI technology enabling doctors and physicians to make accurate diagnosis and improve patient lives. For more information, please visit

About iRAD

Claritas iRAD is the proprietary medical software product of Claritas HealthTech Pte Ltd. The team of imaging specialists, scientists, and mathematicians at Claritas HealthTech, have developed Claritas iRAD and engineered an image enhancement process that preserves the finest details by individually enhancing each pixel to produce an image of high precision. Whether unclear due to radiation, low light or tissue absorption, the unique methods at Claritas HealthTech greatly improves clarity, without distorting, exaggerating or compromising the details of the original image. Claritas iRAD can be seamlessly integrated into any of the existing radiology platforms, such as PACS (Picture archiving and communications systems) Viewer, to support better workflow. With an aim to support medical professionals to better identify the nature of a patient’s illness, Claritas iRAD will simultaneously ensure cost and time efficiency for patients on the account of re-testing, insurance and malpractice claims that often results from a misdiagnosis. For more information on iRAD, please visit

About tRAD

Claritas tRAD is the new Tele-Radiology cloud based solution from Singapore-based Claritas HealthTech Pte. Ltd. (“Claritas”), that acts as a medical imaging and collaborative platform for patients and physicians. In partnership with Google Cloud, tRAD will enable online access for patients to review their radiology images, clinical reports, and communicate with their physicians on a single platform. Built with enterprise clients in mind, tRAD is designed to provide a simple Application Programming Interface (API) level access for any telehealth company to add imaging in their workflow, and will enable radiology image distribution in a fast and collaborative environment. Claritas tRAD maintains their compliance standards with Health Level 7 (HL7), Fast Healthcare Interoperability Resources (FHIR), Digital Imaging and Communications in Medicine (DICOM), as well as Health Insurance Portability and Accountability Act (HIPAA). For more information on tRAD, please visit